March 04, 2025 07:12 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Haryana Congress worker murder: Video emerges showing accused dragging suitcase with Himani Narwal's body inside it | Supreme Court slams 'oversmart' Samay Raina for making fun of proceedings in Canada, asks him to 'behave' | Indian woman facing death row in UAE for killing a child has been executed: Foreign ministry tells court | Crucial to have Trump’s support, says Zelenskyy a day after fiery White House exchange | 'We're looking for peace, Zelenskyy wants Russia-Ukraine war to continue': Donald Trump after White House public spat | Volodymyr Zelenskyy refuses to apologise to Donald Trump after public spat over Russia-Ukraine war | 'Make a deal or we are out': Donald Trump tells Volodymyr Zelenskyy at White House | Himachal govt seeks fund from temple to support welfare schemes, BJP calls move 'shocking' | Injustice to opposition MLAs: Atishi writes to Delhi Assembly Speaker on suspension of 21 AAP lawmakers | We will leave for US tomorrow: Father of Indian student Neelam Shinde after urgent visa grant

AstraZeneca's COVID-19 vaccine trial to resume in US

Oct 24, 2020, at 03:28 pm

Washington/Xinhua: Multinational pharmaceutical company AstraZeneca said on Friday it will resume the trial of its experimental COVID-19 vaccine in the United States, which has been paused since September.

WHO on Johnson&Johnson halting COVID vaccine trial: Safety paramount

Oct 13, 2020, at 09:16 pm

Moscow/Sputnik: The World Health Organization believes that safety in research is crucial and is pleased to see developers acting by the rules, the WHO spokesperson told Sputnik regarding Johnson&Johnson suspending its vaccine trials.

After Oxford Covid-19 Vaccine trial pause, DCGI sends show-cause notice to Serum Institute

Sep 10, 2020, at 04:23 am

New Delhi/IBNS: After pharmaceutical giant AstraZeneca halted the Phase 3 study testing of the Oxford Vaccine against Covid-19, the Drugs Controller General of India (DCGI) on Wednesday issued a show-cause notice to Serum Institute of India (SII) for not informing the central drug regulator about the pause of trials in other countries.

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse reaction seen in participant

Sep 09, 2020, at 01:30 pm

London:  Pharmaceutical company AstraZeneca has halted the Phase 3 study testing of a Covid-19 vaccine after a suspected serious adverse reaction was seen in a participant in the United Kingdom, media reports said.